BioAge Labs
Latest round
- Series D
Last raised
- Feb 2024
Total raised
- $320M
Investors
- 21
About BioAge Labs
Based in California, US, and founded in 2015 by co-founder Kristen Fortney and Eric Morgen, BioAge Labs, Inc. operates as a provider of an artificial intelligence-based platform that helps in discovering and developing drugs for age-related diseases. In February 2024, BioAge Labs, Inc. In September 2024, BioAge Labs, Inc.". BioAge Labs, Inc.65 million shares of common stock as part of the listing.26% minority stake, respectively. BioAge Labs, Inc. focuses on metabolic diseases and neuroinflammation by the molecular mechanisms of aging. The company’s program, azelaprag (BGE-105), which is an oral therapeutic targeting obesity, acts as an APJ agonist, enhancing weight loss and improving body composition used in combination with incretin drugs. It’s program, BGE-100, which is an NLRP3 inhibitor treating metabolic diseases and neuroinflammation, addresses chronic inflammation by inhibiting the inflammasome component NLRP3, which is implicated in various age-related conditions.
Who invested in BioAge Labs
21 investors across 4 rounds
See all investors in BioAge Labs
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about BioAge Labs
Who invested in BioAge Labs?
BioAge Labs has 21 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has BioAge Labs raised?
BioAge Labs has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did BioAge Labs last raise money?
BioAge Labs's most recent round on record is a Series D, in Feb 2024.
What does BioAge Labs do?
Based in California, US, and founded in 2015 by co-founder Kristen Fortney and Eric Morgen, BioAge Labs, Inc.
Where is BioAge Labs headquartered?
BioAge Labs is headquartered in Richmond, US.
Which VCs invest in companies like BioAge Labs?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at BioAge Labs's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series D
Raising like BioAge Labs? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.